Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 940.62 Million | 288.66 Million | 569.32 Million | 693.71 Million | 275.04 Million | 94.45 Million |
| Net Income | 859.96 Million | 519.63 Million | 620.97 Million | 924.9 Million | 375.29 Million | 270.14 Million |
| Depreciation & Amortization | 144.85 Million | 135.43 Million | 68.92 Million | 40.84 Million | 34.05 Million | 26.67 Million |
| Deferred income taxes | -598.47 Thousand | -21.74 Million | -10.26 Million | -83.7 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -129.09 Million | -496.82 Million | -232.94 Million | -341 Million | -178.81 Million | -211.8 Million |
| Other non-cash items | 510.85 Million | 130.42 Million | 112.37 Million | 68.96 Million | 44.49 Million | 9.44 Million |
| Investing Cash Flow | -773.71 Million | -1.75 Billion | -1.09 Billion | -753.32 Million | -140.51 Million | 21.18 Million |
| Investments in PPE | -62.6 Million | -92.64 Million | -636.06 Million | -532.28 Million | -143.89 Million | -62.76 Million |
| Acquisitions | 92 Thousand | 311.72 Thousand | - | 532.28 Million | 143.89 Million | 62.84 Million |
| Investment purchases | -4.85 Billion | -6.82 Billion | -3.58 Billion | -2.51 Billion | -1.12 Billion | -473.11 Million |
| Sales/Maturities of investments | 4.14 Billion | 5.15 Billion | 3.12 Billion | 2.29 Billion | 1.12 Billion | 556.99 Million |
| Other Investing Activities | -1.00 | 0.12 | 0.85 | -532.28 Million | -143.89 Million | -62.76 Million |
| Financing Cash Flow | -126.08 Million | 1.95 Billion | 286.13 Million | 135.69 Million | -0.37 | 0.51 |
| Debt repayment | -300 Million | -500 Million | -500 Million | -50 Million | - | - |
| Dividends payments | -126.08 Million | -90.88 Million | -12.76 Million | -4.58 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -126.08 Million | 2.54 Billion | 798.89 Million | 190.28 Million | - | - |
| Accounts receivables | -224.18 Million | -380.75 Million | 89.37 Million | -906.29 Million | - | - |
| Accounts payables | 170.28 Million | 117.16 Million | -116.66 Million | 669.16 Million | - | - |
| Inventory | -101.74 Million | -211.48 Million | -195.39 Million | -20.17 Million | -26.93 Million | -21.35 Million |
| Other working capital | 26.54 Million | -21.74 Million | -10.26 Million | -83.7 Million | -151.87 Million | -190.45 Million |
| Cash at beginning of period | 600.04 Million | 114.79 Million | 351.19 Million | 275.11 Million | 140.59 Million | 24.94 Million |
| Cash at end of period | 640.98 Million | 600.04 Million | 114.79 Million | 351.19 Million | 275.11 Million | 140.59 Million |
| Capital Expenditure | -62.6 Million | -92.64 Million | -636.06 Million | -532.28 Million | -143.89 Million | -62.76 Million |
| Effect of forex changes on cash | 113.86 Thousand | - | - | 0.02 | -0.46 | -457.51 |
| Net cash flow / Change in cash | 40.93 Million | 485.24 Million | -236.4 Million | 76.07 Million | 134.52 Million | 115.64 Million |
| Free Cash Flow | 878.02 Million | 196.01 Million | -66.73 Million | 161.42 Million | 131.14 Million | 31.68 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 242.08 Million | -13.31 Million | 38.58 Million | 230.25 Million | 859.96 Million | 521.49 Million |
| Depreciation & Amortization | - | 35.1 Million | 35.1 Million | 35.92 Million | 144.85 Million | 35.92 Million |
| Deferred income taxes | - | - | - | - | -598.47 Thousand | 584.96 Million |
| Stock-based compensation | - | - | - | - | - | -14.4 Million |
| Change in working capital | - | - | - | -299.37 Million | -129.09 Million | -570.55 Million |
| Other non-cash items | -131.32 Million | 234.52 Million | 88.39 Million | 451.68 Million | 510.85 Million | -452.11 Million |
| Investing Cash Flow | -772.45 Million | 807.85 Million | -111.85 Million | -151.88 Million | -773.71 Million | -456.56 Million |
| Investments in PPE | -9.54 Million | -6.27 Million | -22.65 Million | -16.45 Million | -62.6 Million | -16.23 Million |
| Acquisitions | - | - | 43 Thousand | 92 Thousand | 92 Thousand | - |
| Investment purchases | -5.86 Billion | -7.32 Billion | -1.54 Billion | -1.95 Billion | -4.85 Billion | -801.97 Million |
| Sales/Maturities of investments | 5.1 Billion | 8.14 Billion | 1.45 Billion | 1.81 Billion | 4.14 Billion | 361.64 Million |
| Other Investing Activities | - | - | -89.2 Million | -1.00 | -1.00 | 0.52 |
| Financing Cash Flow | -69.57 Million | -355.45 Million | -1.51 Million | -1.51 Million | -126.08 Million | -1.41 Million |
| Debt repayment | - | - | - | - | -300 Million | - |
| Dividends payments | - | -332.98 Million | -1.51 Million | -1.51 Million | -126.08 Million | -1.41 Million |
| Common Stock Repurchased | 38.74 Million | -38.74 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -108.32 Million | -316.7 Million | -1.51 Million | -1.51 Million | -126.08 Million | -1.41 Million |
| Accounts receivables | - | - | - | -224.18 Million | -224.18 Million | -814.6 Million |
| Accounts payables | - | - | - | - | 170.28 Million | - |
| Inventory | - | - | - | -101.23 Million | -101.74 Million | 258.38 Million |
| Other working capital | - | - | - | 26.04 Million | 26.54 Million | -14.34 Million |
| Cash at beginning of period | 1.26 Billion | 623.99 Million | 640.98 Million | 375.78 Million | 600.04 Million | 734.25 Million |
| Cash at end of period | 531.25 Million | 1.26 Billion | 623.99 Million | 640.98 Million | 640.98 Million | 375.78 Million |
| Capital Expenditure | -9.54 Million | -6.27 Million | -22.65 Million | -16.45 Million | -62.6 Million | -16.23 Million |
| Effect of forex changes on cash | - | -3515.76 | -45.05 Thousand | 113.86 Thousand | 113.86 Thousand | -5.79 Million |
| Net cash flow / Change in cash | -731.24 Million | 638.5 Million | -16.98 Million | 265.19 Million | 40.93 Million | -358.47 Million |
| Free Cash Flow | 101.22 Million | 179.83 Million | 104.33 Million | 402.03 Million | 878.02 Million | 89.06 Million |
0K05
004770
007390
030530
ATRAV
C3RY